DEA and HHS Extend Telemedicine Flexibilities for Controlled Substance Prescriptions Through 2024 | Baker Donelson
On October 6, 2023, the Drug Enforcement Agency (DEA) and the Department of Health and Human Services (HHS) announced they would further extend the COVID-19 flexibilities allowing for...
Source: jdsupra.com